We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Inhaled Microplastics as Emerging Respiratory Toxicants: From Cellular Mechanisms to Global Health Policy
Summary
This review pulls together a decade of research on tiny plastic particles floating in the air we breathe, finding that once inhaled, they can trigger inflammation, cell damage, and immune disruption deep in the lungs, effects linked to conditions like asthma, COPD, and even lung cancer. The risk may be even greater since these particles often carry other harmful substances like heavy metals along for the ride. That said, scientists still lack standardized ways to measure this exposure, so more consistent research is needed before we fully understand how worried we should be, but it's a good reason to pay attention to air quality and plastic pollution in daily life.
Background: Airborne microplastics (AMPs) are an emerging air pollutant and there are growing concerns about their potential effects on respiratory health due to their persistence, inhalability and ability to carry other toxic pollutants. Methods: Relevant peer-reviewed studies released from 2015 to 2025 were located by searches on PubMed, Scopus, and Web of Science. Data from experimental, epidemiological, and review research were amalgamated to investigate sources of airborne microplastics, routes of exposure, analytical methodologies, respiratory toxicological processes, and regulatory viewpoints. Results: Modern studies suggest inhaled antimicrobic peptides can reach the lower respiratory tract and cause chronic pulmonary inflammation via induction of oxidative stress, mitochondrial dysfunction, epithelial barrier damage, inflammasome activation, immune system imbalance and extracellular matrix remodeling. These pathways have been associated with chronic respiratory diseases, such as chronic obstructive pulmonary disease, asthma, pulmonary fibrosis, and lung carcinoma. Toxicity can be increased by the accumulation of heavy metals, persistent organic pollutants and microbiological impurities. However, the lack of standardised protocols for exposure assessment, inconsistency of sampling and analytical methods and limited human epidemiological data hamper health risk assessment. Conclusions: Airborne microplastics are an emerging environmental health concern with potentially significant effects on respiratory health. Harmonised surveillance strategies, standardised analytical methods, improved inhalation exposure models and prolonged epidemiological studies are urgently needed to improve risk assessment and enable evidence-based air quality policy for the protection of respiratory health.